Telaglenastat
- Generic Name
- Telaglenastat
- Drug Type
- Small Molecule
- Chemical Formula
- C26H24F3N7O3S
- CAS Number
- 1439399-58-2
- Unique Ingredient Identifier
- U6CL98GLP4
Overview
Telaglenastat is under investigation in clinical trial NCT02071862 (Study of the Glutaminase Inhibitor CB-839 in Solid Tumors).
Background
Telaglenastat is under investigation in clinical trial NCT02071862 (Study of the Glutaminase Inhibitor CB-839 in Solid Tumors).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath